Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 14Gynecologic 12Thoracic 4Sarcoma 4Genitourinary 3Gastrointestinal 2Tumor-Agnostic 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 2Carcinoma, Renal Cell 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × fluzoparib × Genitourinary × Clear all
NCT06971211 2025-05-14

PARTOM

First Hospital of China Medical University

Phase 2 Recruiting
40 enrolled
Genitourinary

Prostatic Neoplasms

NCT05223582 2023-12-08

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Fudan University

Phase 2 Unknown
34 enrolled
Genitourinary

Prostatic Neoplasms

NCT04535687 2023-06-13

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Completed
1 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡